Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

87 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
On behalf of the SFGM-TC: Real-life use of third-party virus-specific T-cell transfer in immunocompromised transplanted patients.
Leroyer EH, Petitpain N, Morisset S, Neven B, Castelle M, Winter S, Souchet L, Morel V, Le Cann M, Fahd M, Yacouben K, Mechinaud F, Ouachée-Chardin M, Renard C, Wallet HL, Angoso M, Jubert C, Chevallier P, Léger A, Rialland F, Dhedin N, Robin C, Maury S, Beckerich F, Beauvais D, Cluzeau T, Loschi M, Fernster A, Bittencourt MC, Cravat M, Bilger K, Clément L, Decot V, Gauthier M, Legendre A, Larghero J, Ouedrani A, Martin-Blondel G, Pochon C, Reppel L, Rouard H, Nguyen-Quoc S, Dalle JH, D'Aveni M, Bensoussan D. Leroyer EH, et al. Among authors: beauvais d. Hemasphere. 2024 Jan 27;8(1):e40. doi: 10.1002/hem3.40. eCollection 2024 Jan. Hemasphere. 2024. PMID: 38434523 Free PMC article. No abstract available.
Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002.
Meyers G, Hamadani M, Martens M, Ali H, Chevallier P, Choe H, Harris AC, Holler E, van Hooren E, Klaassen W, Leifer E, van Oosterhout Y, Perez L, Pusic I, Stelljes M, van der Velden W, Ammatuna E, Beauvais D, Cornillon J, Maziarz RT, Schetelig J, Romeril J, MacMillan ML, Levine JE, Socié G. Meyers G, et al. Among authors: beauvais d. Bone Marrow Transplant. 2023 Dec;58(12):1416-1418. doi: 10.1038/s41409-023-02110-4. Epub 2023 Sep 25. Bone Marrow Transplant. 2023. PMID: 37749187 No abstract available.
Transplantation for myelofibrosis patients in the ruxolitinib era: a registry study from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire.
Villar S, Chevret S, Poire X, Joris M, Chevallier P, Bourhis JH, Forcade E, Chantepie S, Beauvais D, Raus N, Bay JO, Loschi M, Devillier R, Duléry R, Ceballos P, Rubio MT, Servais S, Nguyen S, Robin M. Villar S, et al. Among authors: beauvais d. Bone Marrow Transplant. 2024 Jul;59(7):965-973. doi: 10.1038/s41409-024-02268-5. Epub 2024 Mar 21. Bone Marrow Transplant. 2024. PMID: 38514813
[Management of CAR-T cell-related encephalopathy syndrome in adult and pediatric patients: Recommendations of the French Society of Bone Marrow transplantation and cellular Therapy (SFGM-TC)].
Cornillon J, Hadhoum N, Roth-Guepin G, Quessar A, Platon L, Ouachée-Chardin M, Nicolas-Virelizier E, Naudin J, Moreau AS, Masouridi-Levrat S, Borel C, Ahmad I, Beauvais D, Baruchel A, Yakoub-Agha I. Cornillon J, et al. Among authors: beauvais d. Bull Cancer. 2020 Jan;107(1S):S12-S17. doi: 10.1016/j.bulcan.2019.05.001. Epub 2019 Jun 13. Bull Cancer. 2020. PMID: 31202556 French.
[Antiviral prophylaxis for CMV, HSV/VZV and HBV in allogeneic hematopoietic cell transplantation in adult patients: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Brissot E, Alsuliman T, Beauvais D, Bonnin A, Mear JB, Souchet L, Villate A, Yakoub-Agha I, Bazarbachi A. Brissot E, et al. Among authors: beauvais d. Bull Cancer. 2020 Jan;107(1S):S1-S6. doi: 10.1016/j.bulcan.2019.09.002. Epub 2019 Oct 15. Bull Cancer. 2020. PMID: 31627903 Review. French.
The concurrent administration of imatinib with extracorporeal photopheresis leads to complete and durable responses in patients with refractory sclerotic type chronic graft-versus-host disease.
Alsuliman T, Magro L, Coiteux V, Gauthier J, Srour M, Lionet A, Beauvais D, Yakoub-Agha I. Alsuliman T, et al. Among authors: beauvais d. Curr Res Transl Med. 2020 Apr;68(2):71-76. doi: 10.1016/j.retram.2019.10.001. Epub 2019 Oct 17. Curr Res Transl Med. 2020. PMID: 31631014
[Multidrug-resistant bacteria detection in patients undergoing allogeneic hematopoietic cell transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Brissot E, Villate A, Alsuliman T, Beauvais D, Bonnin A, Mear JB, Souchet L, Yakoub-Agha I, Bazarbachi A. Brissot E, et al. Among authors: beauvais d. Bull Cancer. 2020 Jan;107(1S):S7-S11. doi: 10.1016/j.bulcan.2019.09.006. Epub 2019 Oct 18. Bull Cancer. 2020. PMID: 31635753 Review. French.
Clinical and economic impact of treated CMV infection in adult CMV-seropositive patients after allogeneic hematopoietic cell transplantation.
Peffault De Latour R, Chevallier P, Blaise D, Alami S, Lévy-Bachelot L, Allavoine T, Tadmouri A, Blomkvist J, Duhamel A, Srour M, Beauvais D, Yakoub-Agha I. Peffault De Latour R, et al. Among authors: beauvais d. J Med Virol. 2020 Dec;92(12):3665-3673. doi: 10.1002/jmv.25895. Epub 2020 Jun 29. J Med Virol. 2020. PMID: 32297984
Monitoring CAR T-cells using flow cytometry.
Demaret J, Varlet P, Trauet J, Beauvais D, Grossemy A, Hégo F, Yakoub-Agha I, Labalette M. Demaret J, et al. Among authors: beauvais d. Cytometry B Clin Cytom. 2021 Mar;100(2):218-224. doi: 10.1002/cyto.b.21941. Epub 2020 Aug 25. Cytometry B Clin Cytom. 2021. PMID: 32841511 Free article.
87 results